Express I

Company: Boehringer Ingelheim

Bovine Rhinotracheitis Vaccine

Modified Live Virus

Express I Indications

Recommended for the vaccination of healthy, susceptible cattle as an aid in the reduction of disease caused by Bovine Rhinotracheitis (IBR) virus.

Composition

This product contains Bovine Rhinotracheitis (IBR) modified live virus.

Directions For Use

Rehydrate one bottle of modified live virus vaccine by aseptically adding one bottle of liquid diluent. Shake well and use immediately.

Dosage: Using aseptic technique, inject 2 mL subcutaneously. Calves vaccinated before 6 months of age should be revaccinated at 6 months. A 2 mL booster dose is recommended annually.

Precautions

Store out of direct sunlight at a temperature between 35-45°F (2-7°C). Avoid freezing. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Do not use in pregnant cows or calves nursing pregnant cows. Burn vaccine containers and all unused contents. Anaphylactoid reactions may occur.

Antidote: Epinephrine.

Preservative: Neomycin.

Contents: Five 50 dose vials of MLV vaccine and five 100 mL vials of liquid diluent.

Federal regulations prohibit the repackaging or sale of the contents of carton in fractional units. Do not accept if seal is broken.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.S.A.

U.S. Veterinary License No. 124

NAC No.: 10281314